ClinicalTrials HQ

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, China

18 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast CancerAdvanced Breast CancerRecruitingNot applicable2026-08-19NCT05876065
Pre-operative Therapy in Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2026-08-04NCT05621564
The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast CancerBreast Cancer InvasiveActive, not recruitingNot stated2026-05-15NCT07590570
The Association Between Blood Routine Parameters and Breast Cancer PrognosisBreast Cancer InvasiveActive, not recruitingNot stated2026-05-13NCT07584213
Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast CancerHR-positive/HER2-negative Breast CancerRecruitingPhase 22026-05-13NCT07396324
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer PrognosisBreast Cancer InvasiveActive, not recruitingNot stated2026-05-13NCT07283718
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaRecruitingPhase 22026-05-13NCT07283692
RC48-ADC in HER2-low Advanced Breast CancerAdvanced Breast CancerRecruitingNot applicable2026-05-13NCT05831878
Dalpiciclib in HR+/HER2- ABCAdvanced Breast CancerRecruitingNot stated2026-02-03NCT06301438
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2025-11-19NCT07180056
Trastuzumab Deruxtecan in Advanced Breast CancerAdvanced Breast CancerRecruitingNot stated2025-11-18NCT07180264
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast CancerAdvanced Breast CancerRecruitingPhase 22025-11-18NCT07180160
Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast CancerAdvanced Breast CancerRecruitingPhase 22025-11-18NCT07180082
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast CancerBreast Cancer InvasiveRecruitingPhase 32025-11-18NCT05910398
Disitamab Vedotin (RC48-ADC) in Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2025-09-17NCT05851677
Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral NeuropathyNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingNot applicable2025-09-12NCT07169864
Study of Acupuncture to Control Weight and Improve Pregnancy Rates in Overweight/Obese PCOS PatientsAdnexal Diseases, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endocrine system disorder, female reproductive system disorder, gonadal disorder, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndromeNot yet recruitingNot applicable2024-12-04NCT06717087
OXiris for Abdominal SEptic Shock (OASES Study)Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Intraabdominal Infections, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, multiple organ dysfunction syndrome, toxic shock syndrome, urinary system disorderNot yet recruitingNot applicable2024-07-16NCT06504316